ROBERT JOHNSTON: Open Payments
NPI 1649272907 · LA PORTE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 77 payments from 27 companies in 2025. Trend: 2023 $2,117 · 2024 $905 · 2025 $1,532
Food & beverage: $1,532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $195 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $147 |
| Neurocrine BioSciences, Inc. | 4 | $140 |
| Aimmune Therapeutics, Inc. | 6 | $137 |
| Novo Nordisk Inc | 4 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $83 |
| Vanda Pharmaceuticals Inc. | 4 | $75 |
| VIVUS LLC | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Nalu Medical, Inc. | 1 | $58 |
Products named: CAPLYTA, INGREZZA, ZENPEP, VRAYLAR, Kerendia, PANCREAZE, Nalu Neurostimulation System, XIFAXAN.
Industry payments across TX — which companies pay providers there.
